share_log

Shareholder Alert: Ademi LLP Investigates Whether Reneo Pharmaceuticals, Inc. Has Obtained a Fair Price in Its Transaction With OnKure

Shareholder Alert: Ademi LLP Investigates Whether Reneo Pharmaceuticals, Inc. Has Obtained a Fair Price in Its Transaction With OnKure

股东提醒:Ademi LLP正在调查Reneo Pharmicals, Inc. 在与OnKure的交易中是否获得了公平的价格
PR Newswire ·  05/13 12:02

MILWAUKEE, May 13, 2024 /PRNewswire/ -- Ademi LLP is investigating Reneo (Nasdaq: RPHM) for possible breaches of fiduciary duty and other violations of law in its going private transaction with OnKure.

密尔沃基,2024年5月13日 /PRNewswire/ — Ademi LLP正在调查Reneo(纳斯达克股票代码:RPHM)在与OnKure的私有交易中可能违反信托义务和其他违法行为

Click here to learn how to join the or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

点击此处了解如何加入或拨打 Guri Ademi 的免费电话 866-264-3995。您无需支付任何费用或承担任何义务。

In the transaction, pre-merger Reneo stockholders are expected to own approximately 31% of the combined company, and pre-merger OnKure stockholders are expected to own approximately 69% of the combined company. The transaction agreement unreasonably limits competing transactions for Reneo by imposing a significant penalty if Reneo accepts a competing bid. Reneo insiders will receive substantial benefits as part of change of control arrangements.

在交易中,合并前的Reneo股东预计将拥有合并后公司约31%的股份,合并前的OnKure股东预计将拥有合并后公司约69%的股份。如果Reneo接受竞争性出价,该交易协议将处以巨额罚款,从而不合理地限制了Reneo的竞争交易。作为控制权变更安排的一部分,Reneo内部人士将获得可观的收益。

We are investigating the conduct of Reneo's board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

我们正在调查Reneo董事会的行为,以及他们是否履行了对所有股东的信托责任。

If you own Reneo common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or

如果您拥有Reneo普通股并希望获得更多信息,请致电 [email protected] 或免费电话:866-264-3995 与 Guri Ademi 联系,或

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

我们专门处理涉及收购、合并和全国各地个人股东权利的股东诉讼。欲了解更多信息,请随时致电我们。律师广告。先前的结果并不能保证类似的结果。

Contacts

联系人

Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

Ademi LLP
Guri Ademi
免费电话:(866) 264-3995
传真:(414) 482-8001

SOURCE Ademi LLP

来源 Ademi LLP

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发